2026 年 3 月 24 日，Investing.com 发布了一篇题为“ADMA Biologics 股价因卖空者指控而暴跌”的文章。文章指出，在卖空机构 Culper Research 发布一份报告，指控该公司通过“渠道填充”（channel stuffing）来夸大收入增长后，ADMA Biologics 的股价出现下跌。
受此消息影响，ADMA Biologics 的股价在 2026 年 3 月 24 日下跌了 16.6%。
If you purchased ADMA Biologics securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
公司名称:
ADMA Biologics Inc.
股票代号:
ADMA
集体诉讼期:
N/A
法院:
N/A
The Rosen Law Firm has been ranked among the top 4 law firms each year since 2013 for the number of successful securities class actions on behalf of investors. In 2019 alone, our firm recovered $438 million for investors.
投资者应仔细鉴别和遴选在引领证券集体诉讼方面有多年成功经验的的律师。通常，其他律所会发布关于集体诉讼的新闻稿，但却没有类似的经验或资源。
机构股东服务公司按 2017 年证券集体诉讼索赔数量，罗森律师事务所列为第一名。
The Rosen Law Firm represents investors throughout the globe. Our mission is to prosecute securities fraud class actions and protect shareholders’ rights.
